ACE and hypertensive heart disease: In line, the ACE inhibitor lisinopril or the ARB losartan were associated with reducing the extent of reactive fibrosis together with LV stiffness, and improving LV diastolic dysfunction, when given to small cohorts of patients with hypertensive heart disease (178, 179).